Amprenavir/ritonavir

DRUG2 trials

Sponsors

Abbott

Conditions

HIV Infections

Phase 2

Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subjects Following Failure With Kaletra (ABT-378/Ritonavir) as Their First Protease Inhibitor Based HAART

CompletedNCT00038532

AbbottHIV Infections

Start: 2001-04-30Target: 24Updated: 2008-04-01

Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following Failure With Kaletra as Their Second Protease Inhibitor

CompletedNCT00038519

AbbottHIV Infections

Start: 2001-04-30Target: 16Updated: 2006-07-28